Mipragoside
Alternative Names: AGF 44Latest Information Update: 10 Oct 2003
At a glance
- Originator Fidia Farmaceutici
- Class Anti-inflammatories; Antiallergics; Antirheumatics; Gangliosides
- Mechanism of Action Cell membrane permeability inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 10 Oct 2003 Discontinued - Phase-I for Inflammation in Italy (unspecified route)
- 01 Jul 1998 No-Development-Reported for Inflammation in Italy (Unknown route)
- 03 Nov 1994 Phase-I clinical trials for Inflammation in Italy (Unknown route)